Internal Medicine, Endocrinology, Diabetes, & Metabolism · Dubuque, IA
NPI
1265407589
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Delhi St, Ste 100
Dubuque, IA, 52001
Phone (563) 557-9111
Groups this clinician bills Medicare through
Medicare paid, 2024
$150K
26,867 services
Medicare patients, 2024
1,286
Average age 71
Drug cost, 2024
$1.9M
4,513 prescriptions
Company payments, 2025
$408
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald A Iverson was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 4,960 times for 50 patients. In total Ronald A Iverson billed 26,867 services in 126 codes, and Medicare paid $150K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,960 | 50 | $0.10 | $509 |
| 36415 Venipuncture Blood Collection | Office | 742 | 441 | $8.61 | $6,391 |
| 77080 Standard X-ray | Office | 359 | 359 | $34.96 | $13K |
| 77063 Mammography | Office | 353 | 353 | $21.37 | $7,545 |
| 77067 Mammography | Office | 353 | 353 | $82.10 | $29K |
| 85025 Blood Count | Office | 255 | 149 | $7.59 | $1,934 |
| 99213 Office E&M - Established | Office | 187 | 166 | $57.72 | $11K |
| 83036 Blood Count | Office | 172 | 118 | $9.43 | $1,622 |
| 85652 Clinical Chemistry | Office | 142 | 80 | $2.65 | $376 |
| 82565 Clinical Chemistry | Office | 139 | 102 | $5.02 | $698 |
| 84443 Clinical Chemistry | Office | 134 | 101 | $16.46 | $2,206 |
| 99214 Office E&M - Established | Office | 115 | 95 | $80.21 | $9,225 |
| 80076 Clinical Chemistry | Office | 114 | 59 | $7.95 | $907 |
| G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 97 | 81 | $12.39 | $1,202 |
| 96372 Injection Administration | Office | 89 | 14 | $9.38 | $835 |
By year: 2022 $145K for 24,745 services; 2023 $154K for 25,622 services; 2024 $150K for 26,867 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 742 | 441 | $8.61 | $6,391 |
| 85025 Blood Count | 255 | 149 | $7.59 | $1,934 |
| 83036 Blood Count | 172 | 118 | $9.43 | $1,622 |
| 85652 Clinical Chemistry | 142 | 80 | $2.65 | $376 |
| 82565 Clinical Chemistry | 139 | 102 | $5.02 | $698 |
| 84443 Clinical Chemistry | 134 | 101 | $16.46 | $2,206 |
| 80076 Clinical Chemistry | 114 | 59 | $7.95 | $907 |
| 80048 Clinical Chemistry | 89 | 49 | $8.07 | $718 |
| 86140 Clinical Chemistry | 84 | 58 | $5.08 | $427 |
| 80053 Clinical Chemistry | 84 | 61 | $10.25 | $861 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald A Iverson prescribed most often to Medicare patients was Levothyroxine Sodium, with 538 prescriptions and refills. In total Ronald A Iverson wrote 4,513 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 538 | 1,220 | 110 | $4,374 |
| Glimepiride Generic | 274 | 656 | 71 | $1,955 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 264 | 637 | 81 | $53K |
| Jardiance Empagliflozin | 204 | 454 | 47 | $254K |
| Humalog Kwikpen U-100 Insulin Lispro | 182 | 350 | 56 | $79K |
| Metformin Hcl Generic | 178 | 464 | 46 | $1,567 |
| Ozempic Semaglutide | 160 | 244 | 34 | $224K |
| Methimazole Generic | 136 | 249 | 28 | $1,730 |
| Mounjaro Tirzepatide | 129 | 156 | 19 | $161K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 125 | 239 | 35 | $91K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 89 | 216 | 35 | $8,446 |
| Tradjenta Linagliptin | 75 | 123 | 12 | $62K |
| Pioglitazone Hcl Generic | 75 | 197 | 20 | $940 |
| Novolog Flexpen Insulin Aspart | 73 | 123 | 27 | $27K |
| Metformin Hcl Er Metformin Hcl | 71 | 183 | 21 | $1,221 |
Brand drugs: 2,413 claims; generic drugs: 1,649 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald A Iverson $408 ($408 in general payments such as food, travel and fees) from 11 companies. The largest payer was Amgen Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.